Neovasc Hit With $70M Verdict In IP, Trade Secrets Trial
A Massachusetts federal jury on Thursday slammed Neovasc Inc. with $70 million in damages in a medical device patent lawsuit, finding the Canadian biotech firm stole trade secrets from rival CardiAQ...To view the full article, register now.
Already a subscriber? Click here to view full article